Vita S. Brawley

4.1k total citations
14 papers, 1.2k citations indexed

About

Vita S. Brawley is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Vita S. Brawley has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Immunology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vita S. Brawley's work include CAR-T cell therapy research (12 papers), Immunotherapy and Immune Responses (8 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Vita S. Brawley is often cited by papers focused on CAR-T cell therapy research (12 papers), Immunotherapy and Immune Responses (8 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Vita S. Brawley collaborates with scholars based in United States, Germany and France. Vita S. Brawley's co-authors include Nabil Ahmed, Stephen Gottschalk, Helen E. Heslop, Meenakshi Hegde, Amanda Corder, Tiara T. Byrd, Alexia Ghazi, Donald R. Shaffer, Yvonne Kew and Hao Liu and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Cancer Research.

In The Last Decade

Vita S. Brawley

14 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vita S. Brawley United States	10	1.0k	442	429	326	313	14	1.2k
Kevin Chow United States	11	982 0.9×	382 0.9×	416 1.0×	263 0.8×	270 0.9×	16	1.2k
Darya Alizadeh United States	13	942 0.9×	393 0.9×	514 1.2×	220 0.7×	417 1.3×	25	1.3k
Zhongzhen Yi United States	11	1.0k 1.0×	418 0.9×	459 1.1×	294 0.9×	283 0.9×	17	1.2k
Meenakshi Hegde United States	13	1.4k 1.3×	607 1.4×	538 1.3×	423 1.3×	414 1.3×	36	1.6k
Sunitha Kakarla United States	9	936 0.9×	296 0.7×	403 0.9×	229 0.7×	274 0.9×	13	1.1k
Tiara T. Byrd United States	10	1.0k 1.0×	496 1.1×	430 1.0×	315 1.0×	271 0.9×	18	1.2k
Araceli Naranjo United States	8	1.3k 1.3×	484 1.1×	610 1.4×	420 1.3×	335 1.1×	14	1.5k
Mark B. Leick United States	16	1.4k 1.4×	505 1.1×	518 1.2×	408 1.3×	526 1.7×	47	1.8k
Andrea Schmidts United States	15	1.3k 1.3×	542 1.2×	520 1.2×	446 1.4×	762 2.4×	30	1.8k
Carter M. Suryadevara United States	16	754 0.7×	292 0.7×	411 1.0×	171 0.5×	224 0.7×	31	1.0k

Countries citing papers authored by Vita S. Brawley

Since Specialization

Citations

This map shows the geographic impact of Vita S. Brawley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vita S. Brawley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vita S. Brawley more than expected).

Fields of papers citing papers by Vita S. Brawley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vita S. Brawley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vita S. Brawley. The network helps show where Vita S. Brawley may publish in the future.

Co-authorship network of co-authors of Vita S. Brawley

This figure shows the co-authorship network connecting the top 25 collaborators of Vita S. Brawley. A scholar is included among the top collaborators of Vita S. Brawley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vita S. Brawley. Vita S. Brawley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Hegde, Meenakshi, Christopher DeRenzo, Huimin Zhang, et al.. (2017). Expansion of HER2-CAR T cells after lymphodepletion and clinical responses in patients with advanced sarcoma.. Journal of Clinical Oncology. 35(15_suppl). 10508–10508. 34 indexed citations

Hegde, Meenakshi, Zakaria Grada, Antonella Pignata, et al.. (2015). A bispecific chimeric antigen receptor molecule enhances T cell activation through dual immunological synapse formation and offsets antigen escape in glioblastoma. Journal for ImmunoTherapy of Cancer. 3(S2). 6 indexed citations

Ahmed, Nabil, Vita S. Brawley, Oumar Diouf, et al.. (2015). Autologous HER2 CMV bispecific CAR T cells for progressive glioblastoma: Results from a phase I clinical trial.. Journal of Clinical Oncology. 33(15_suppl). 3008–3008. 8 indexed citations

Mukherjee, Malini, Tiara T. Byrd, Vita S. Brawley, et al.. (2014). Overexpression and constitutive nuclear localization of cohesin protease Separase protein correlates with high incidence of relapse and reduced overall survival in glioblastoma multiforme. Journal of Neuro-Oncology. 119(1). 27–35. 25 indexed citations

Hegde, Meenakshi, Amanda Wakefield, Vita S. Brawley, et al.. (2014). Genetic modification of T cells with a novel bispecific chimeric antigen receptor to enhance the control of high-grade glioma (HGG).. Journal of Clinical Oncology. 32(15_suppl). 10027–10027. 9 indexed citations

Hegde, Meenakshi, Amanda Corder, Zakaria Grada, et al.. (2014). A bispecific chimeric antigen receptor targeting antigen escape variants in glioblastoma. Cytotherapy. 16(4). S28–S28. 1 indexed citations

Hegde, Meenakshi, Amanda Corder, Kevin Chow, et al.. (2013). Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma. Molecular Therapy. 21(11). 2087–2101. 299 indexed citations

Glasgow, Stacey M., Vita S. Brawley, Zhiyuan Zhang, et al.. (2013). The miR-223/Nuclear Factor I-A Axis Regulates Glial Precursor Proliferation and Tumorigenesis in the CNS. Journal of Neuroscience. 33(33). 13560–13568. 46 indexed citations

Grada, Zakaria, Meenakshi Hegde, Tiara T. Byrd, et al.. (2013). TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy. Molecular Therapy — Nucleic Acids. 2. e105–e105. 378 indexed citations

10.

Liu, Daofeng, Liping Song, Vita S. Brawley, et al.. (2013). Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells. Clinical Immunology. 149(1). 55–64. 61 indexed citations

11.

Chow, Kevin, Swati Naik, Sunitha Kakarla, et al.. (2012). T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma. Molecular Therapy. 21(3). 629–637. 196 indexed citations

12.

Ghazi, Alexia, Aidin Ashoori, Patrick J. Hanley, et al.. (2012). Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of Glioblastoma. Journal of Immunotherapy. 35(2). 159–168. 60 indexed citations

13.

Ahmed, Nabil, Vita S. Brawley, Oumar Diouf, et al.. (2012). Abstract 3500: T cells redirected against HER2 for the adoptive immunotherapy for HER2-positive osteosarcoma. Cancer Research. 72(8_Supplement). 3500–3500. 7 indexed citations

14.

Rainusso, Nino, Vita S. Brawley, Alexia Ghazi, et al.. (2011). Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma. Cancer Gene Therapy. 19(3). 212–217. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact